Stock data

大樹 (6469)

大樹 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$1.60B, up 5.4% from a year earlier. EPS over the last four quarters totals NT$3.16.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 大樹 in Insightr